RE: Microbiome Article20 Jan 2021 16:34
Surely with the large number of covid patients since we started recruiting for our Covid 19 Phase 2 in July we will be getting some update this quarter?
I really think this could be something that has been massively overlooked by the market and would like to share this from an article posted by a fellow poster recently.
The dysbiotic gut microbiota that persists after disease resolution could be a factor in developing persistent symptoms and/or multi system inflammation syndromes that occur in some patients after clearing the virus,” the researchers conclude. “Bolstering of beneficial gut species depleted in COVID-19 could serve as a novel avenue to mitigate severe disease, underscoring importance of managing patients’ gut microbiota during and after COVID-19